Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9cef91d05dc0c7cde1082c1009c6500f |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-533 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-531 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-141 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2330-51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-336 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-335 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-334 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-713 |
filingDate |
2014-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c855dc610a959e7955a00fa7f3b1590a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4546561fe5746e21860ceee0f84b99dc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_446083fe0800968d9098c355260b35e8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66708974f4f0798fb7aaae2d2e1b2744 |
publicationDate |
2015-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2015030616-A4 |
titleOfInvention |
Use of nucleic acid molecules in therapy of diseases induced by expansion of trinucleotide cag repeats |
abstract |
Subjects of the invention are: nucleic acid molecule, expression cassette, expression vector, eukaryotic host cell, induction method of RNA interference in eukaryotic host and use of nucleic acid molecule in therapy of diseases induced by expansion of trinucleotide CAG-type repeats. Solution relates to the new concept of treating hereditary human neurological diseases caused by expansion of CAG-type trinucleotide repeats using RNA interference technology. |
priorityDate |
2013-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |